Literature DB >> 10397621

Soft drugs based on hydrocortisone: the inactive metabolite approach and its application to steroidal antiinflammatory agents.

R J Little1, N Bodor, T Loftsson.   

Abstract

PURPOSE: The soft drug approach was applied to the design of analogs of highly potent synthetic steroids but with a metabolically labile ester group which at the same time served as an activating group.
METHODS: Several structural modifications of soft antiinflammatory steroids were synthesized and tested in several assays of biological activity. The hydrolytic stability of the compounds was also determined.
RESULTS: One of the compounds synthesized was determined to be a very potent steroid and had a highly significant separation of topical from systemic activity. However, the compound demonstrated greater than expected stability in the hydrolysis studies.
CONCLUSIONS: The goal of the soft drug approach has been achieved with the development of a highly potent drug which displays little or no systemic activity as measured in the tests presented here. The anticipated hydrolytic instability of the compounds was not corroborated; however, in view of other results, the interpretation is allowed that the rapid hydrolysis of the unbound fraction of the drug is an important factor in its lack of systemic effects.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10397621     DOI: 10.1023/a:1018907026460

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  16 in total

1.  The effect of corticosteroid analogues on the thymus gland of the immature rat.

Authors:  N R STEPHENSON
Journal:  J Pharm Pharmacol       Date:  1960-07       Impact factor: 3.765

2.  [On the mechanism of cortisone inhibition of connective tissue proliferation].

Authors:  R MEIER; W SCHULER; P DESAULLES
Journal:  Experientia       Date:  1950-12-15

3.  Orally active esters of cephalosporin antibiotics. Synthesis and biological properties of acyloxymethyl esters of 7-(D-2-amino-2-phenylacetamido)-3-[5-methyl-(1,3,4-thiadiazol-2-yl)thiomethyl]-3-cephem-4-carboxylic acid.

Authors:  W J Wheeler; W E Wright; V D Line; J A Froggé
Journal:  J Med Chem       Date:  1977-09       Impact factor: 7.446

4.  [Pharmacolinetics and biotransformation of fluocortin butylester in man (author's transl)].

Authors:  W Mützel
Journal:  Arzneimittelforschung       Date:  1977

5.  Comments concerning "Pharmacokinetic characterization and tissue distribution of the new glucocorticoid soft drug loteprednol etabonate in rats and dogs".

Authors:  K B Sloan; J H Perrin
Journal:  J Pharm Sci       Date:  1994-07       Impact factor: 3.534

Review 6.  Cortoic acids: explorations at the frontier of corticosteroid metabolism.

Authors:  C Monder; H L Bradlow
Journal:  Recent Prog Horm Res       Date:  1980

7.  Improved delivery through biological membranes XD: Percutaneous absorption and metabolism of methylsulfinylmethyl 2-acetoxybenzoate and related aspirin prodrugs.

Authors:  T Loftsson; N Bodor
Journal:  J Pharm Sci       Date:  1981-07       Impact factor: 3.534

8.  Effect on plasma cortisol level and urinary cortisol excretion, in healthy volunteers, after application of three different topical steroid ointments under occlusion.

Authors:  M Scott; L A Malmsten; I Thelin
Journal:  Acta Derm Venereol       Date:  1981       Impact factor: 4.437

9.  Soft drugs. 2. Soft alkylating compounds as potential antitumor agents.

Authors:  N Bodor; J J Kaminski
Journal:  J Med Chem       Date:  1980-05       Impact factor: 7.446

10.  Antiinflammatory activities of 17,21-methyl ortho esters, 17-mono- and 17,21-diesters of 6 ,9 -difluorocorticosteroids.

Authors:  R Gardi; R Vitali; G Falconi; A Ercoli
Journal:  J Med Chem       Date:  1972-05       Impact factor: 7.446

View more
  5 in total

1.  Modeling of human corticosteroid binding globulin. Use of structure-activity relations in soft steroid binding to refine the structure.

Authors:  Roy J Little; C G Rodríguez
Journal:  Pharm Res       Date:  2005-08-16       Impact factor: 4.200

Review 2.  Chemical delivery systems and soft drugs: Retrometabolic approaches of drug design.

Authors:  Yashumati Ratan Bhardwaj; Ashutosh Pareek; Vivek Jain; Dharma Kishore
Journal:  Saudi Pharm J       Date:  2013-05-09       Impact factor: 4.330

3.  Inhibition by new glucocorticoid antedrugs [16α, 17α-d] isoxazoline and [16α, 17α-d]-3'-hydroxy-iminoformyl isoxazoline derivatives of chemotaxis and CCL26, CCL11, IL-8, and RANTES secretion.

Authors:  Younes J Errahali; Leeshawn D Thomas; Thomas C S Keller; Henry J Lee
Journal:  J Interferon Cytokine Res       Date:  2013-05-16       Impact factor: 2.607

Review 4.  Synthesis and pharmacology of anti-inflammatory steroidal antedrugs.

Authors:  M Omar F Khan; Henry J Lee
Journal:  Chem Rev       Date:  2008-12       Impact factor: 60.622

5.  Action of AferBio (fermented food) in a rat inflammatory model.

Authors:  Anna Eliza Maciel de Faria Mota Oliveira; Benedito Junior Lima de Medeiros; Hugo Alexandre Favacho; José Carlos Tavares Carvalho
Journal:  J Exp Pharmacol       Date:  2012-09-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.